Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
CaliPharms, Inc. (KGET)
Temecula, US
CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector. It rebranded to CaliPharms, Inc. in January 2017, having previously operated under the name Kleangas Energy Technologies, Inc. The corporate headquarters for CaliPharms, Inc. are located in Temecula, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3,900.00% | +3,900.00% | +3,900.00% | +3,900.00% | +3,900.00% | +3,900.00% | +3,900.00% | +3,900.00% | -60.00% | -60.00% | -99.96% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Agricultural Inputs: +9.5%—
-
EPS growth Agricultural Inputs: +23.0%+0.0% Q3'14: -1,467.8% (vs Q3'13)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%-6,105.6% Q3'14: -416.8% (vs Q3'13)
-
EBIT margin Agricultural Inputs: +9.7%-11,222.7% Q3'14: -6,114.6% (vs Q3'13)
-
ROIC Agricultural Inputs: +7.4%— Q3'14: +170.8% (vs Q3'13)
-
Share dilution Agricultural Inputs: +0.0%+67.0% Q3'14: +39.2% (vs Q3'13)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×-0.27× Q3'14: -0.24× (vs Q3'13)
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bo Linton | President & Chairman | — | male |
| Brian Wayne Geer | Secretary and Director | — | male |
| Eric Watson | Chief Executive Officer | — | male |
| Maxine Pierson | Executive Vice President In Charge of Mergers & Acquisitions and Member of Advisory Board | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KGET
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
